AIM stock touches 52-week low at $0.13 amid market challenges
In a challenging market environment, Hemispherx Biopharma Inc (NYSE:AIM), trading under the ticker AIM, has seen its stock price touch a 52-week low, reaching a sobering $0.13, marking an 82% decline ...
This is what happens to the body when HIV drugs are stopped for millions of people
Trump's foreign aid freeze is causing chaos in a system that, for over 20 years, has kept millions of people alive.
Unofficial TikTok downloads surge in the US
TikTok's uncertain future in the US has caused a surge in people putting the app on their phones through unofficial means, ...
New Income Tax Bill 2025: Read full text of proposed new I-T Act
Finance Minister Nirmala Sitharaman presented the New Income Tax Bill 2025 in Lok Sabha, aiming to replace the 64-year-old l ...
Chinese animated film shatters box office records as it heads overseas
Ne Zha 2” has earned almost $1.3 billion, becoming China’s highest-grossing movie of all time and the first non-Hollywood ...
Sonya Massey’s family reach a $10 million settlement following fatal 911 call
Six months after what turned into a fatal 911 call in 2024, Sangamon County officials have agreed to a $10 million settlement ...